Literature DB >> 18197885

Comparison of soluble ICAM-1, VCAM-1 and E-selectin levels in patients with episodic cluster headache and giant cell arteritis.

A I M Nilsson Remahl1, J Bratt, H Möllby, E Nordborg, E Waldenlind.   

Abstract

The pathophysiology of cluster headache (CH) is supposed to involve the lower posterior part of the hypothalamus, the trigeminal nerve, autonomic nerves and vessels in the orbital/retro-orbital region. The exact connection of this hypothalamic-trigemino-autonomic-vascular axis is not fully understood. The presence of inflammation in the perivascular tissue of the retro-orbital region has been presented as a possible mechanism behind the pain and the sympatheticoplegia sometimes observed during headache attacks. In a previous study we found neither increased levels of erythrocyte sedimentation rate, C-reactive protein or acute-phase reactants nor clinical signs of a generalized inflammatory disorder. However, these tests may not be sensitive enough to detect a focal inflammatory process in the retro-orbital region. In the present study, we analysed serum levels of three soluble adhesion molecules; soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) in patients with episodic CH and in patients with biopsy-positive giant cell arteritis (GCA), a known vasculitic disorder of large and medium-sized arteries. A control group of healthy volunteers was also included. Within the CH group, sICAM-1, sVCAM-1 and sE-selectin showed an increasing trend in remission compared with the active CH period, but the difference was statistically significant for sE-selectin only. The mean sICAM-1 value was higher in patients with active GCA than in CH patients during the active cluster period. Compared with the healthy control group, the mean levels of soluble adhesion molecules in CH patients also tended to be higher, but statistically significantly so only for sVCAM-1. We hypothesize that CH is not a vasculitic disorder of the medium-sized arteries, but CH patients may have an immune response that reacts differently from that of healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197885     DOI: 10.1111/j.1468-2982.2007.01487.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

1.  Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis.

Authors:  Alicia Rodriguez-Pla; Roscoe L Warner; David Cuthbertson; Simon Carette; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry W Moreland; Christian Pagnoux; Philip Seo; Ulrich Specks; Antoine G Sreih; Steven R Ytterberg; Kent J Johnson; Peter A Merkel; Paul A Monach
Journal:  J Rheumatol       Date:  2019-09-01       Impact factor: 4.666

Review 2.  Role of nitric oxide in cluster headache.

Authors:  Anna Steinberg; A Ingela M Nilsson Remahl
Journal:  Curr Pain Headache Rep       Date:  2012-04

3.  Soluble intercellular adhesion molecule-1: a potential biomarker for pain intensity in chronic pain patients.

Authors:  Benjamin Luchting; Ludwig Christian Giuseppe Hinske; Banafscheh Rachinger-Adam; Leo Anthony Celi; Simone Kreth; Shahnaz Christina Azad
Journal:  Biomark Med       Date:  2017-02-16       Impact factor: 2.851

4.  Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine.

Authors:  Fengzhi Wang; Qiu He; Zhanxiu Ren; Fuyong Li; Wei Chen; Xiang Lin; Hemin Zhang; Guofeng Tai
Journal:  Neurol Sci       Date:  2014-11-23       Impact factor: 3.307

5.  C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study.

Authors:  L S Gudmundsson; T Aspelund; A I Scher; G Thorgeirsson; M Johannsson; L J Launer; V Gudnason
Journal:  Cephalalgia       Date:  2009-04-28       Impact factor: 6.292

6.  Identifying a gene expression signature of cluster headache in blood.

Authors:  Else Eising; Nadine Pelzer; Lisanne S Vijfhuizen; Boukje de Vries; Michel D Ferrari; Peter A C 't Hoen; Gisela M Terwindt; Arn M J M van den Maagdenberg
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

7.  The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines.

Authors:  Mahnaz Rezaei Kelishadi; Amirmansour Alavi Naeini; Fariborz Khorvash; Gholamreza Askari; Zahra Heidari
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.